लोड हो रहा है...

Regulatory and clinical considerations for biosimilar oncology drugs

Biological oncology products are integral to cancer treatment, but their high costs pose challenges to patients, families, providers, and insurers. The introduction of biosimilar agents—molecules that are similar in structure, function, activity, immunogenicity, and safety to the original biological...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Lancet Oncol
मुख्य लेखकों: Bennett, Charles L, Chen, Brian, Hermanson, Terhi, Wyatt, Michael D, Schulz, Richard M, Georgantopoulos, Peter, Kessler, Samuel, Raisch, Dennis W, Qureshi, Zaina P, Lu, Z Kevin, Love, Bryan L, Noxon, Virginia, Bobolts, Laura, Armitage, Melissa, Bian, John, Ray, Paul, Ablin, Richard J, Hrushesky, William J, Macdougall, Iain C, Sartor, Oliver, Armitage, James O
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2014
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404762/
https://ncbi.nlm.nih.gov/pubmed/25456378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70365-1
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!